Effect of pre-operative red blood cell distribution on cancer stage and morbidity rate in patients with pancreatic cancer


YILMAZ A., Malya F., ÖZTÜRK G., Citgez B., ÖZDENKAYA Y., Ersavas C., ...Daha Fazla

International Journal of Clinical and Experimental Medicine, cilt.7, sa.9, ss.3072-3075, 2014 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 7 Sayı: 9
  • Basım Tarihi: 2014
  • Dergi Adı: International Journal of Clinical and Experimental Medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.3072-3075
  • Anahtar Kelimeler: Pancreatic cancer, stage, red cell distribution
  • İstanbul Medipol Üniversitesi Adresli: Evet

Özet

Background: The red blood cell distribution (RDW) is a test measure of erythrocyte variation and the volume level which shows the heterogeneity and it is a proven test in literature for the determination of survival on cardiovascular diseases. The main purpose of this research is to investigate the relationship between the RDW level and postoperative morbidity as well as its stages in diagnosed pancreatic cancer patients. Methods: In this study we covered 104 diagnosed pancreatic cancer patients who have been operated in 2011-2014. The RDW levels were separated into two groups. Group 1 contains higher level RDW patients (> 14) whereas group 2 contains only lower level RDW patients. We compared both groups in terms of the patients’ demographic data, duration of hospitalization, ratio of pancreatic fistula, disease period, and the mortality rates. Results: In group 1 contains 39 patients whereas group 2 contains only 65 patients. We determined the positive correlation between stages of disease with RDW levels as well as the correlation between low level of blood albumin and Ca 19.9 levels (p = 0001). However we did not observe statistically important difference in postoperative morbidity. Conclusions: Based on this study we report that RDW levels can be use as a marker to show the stages of pancreatic cancer in diagnosed patients.